Histologic grading of prostate cancer: A perspective

Byar, 1973, The Veterans Administration Cooperative Urologic Group's studies of cancer of the prostate, Cancer, 32, 1126, 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C

Blackard, 1970, Incidence of cardiovascular disease in patients receiving diethylstilbestrol for carcinoma of the prostate, Cancer, 26, 249, 10.1002/1097-0142(197008)26:2<249::AID-CNCR2820260202>3.0.CO;2-7

Gleason, 1974, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging, J Urol, 111, 58, 10.1016/S0022-5347(17)59889-4

Gleason, 1977, Histologic grading and clinical staging of carcinoma of the prostate, 171

Bain, 1982, Feasibility of grading prostatic carcinomas, Arch Pathol Lab Med, 106, 265

Corriere, 1970, Prognosis in patients with carcinoma of the prostate, Cancer, 25, 911, 10.1002/1097-0142(197004)25:4<911::AID-CNCR2820250426>3.0.CO;2-Y

Sogani, 1985, Gleason grading of prostate cancer: A predictor of survival, Urology, 25, 223, 10.1016/0090-4295(85)90316-4

Nemoto, 1987, Experience with Gleason histopathologic grading of prostate cancer in Japan, Urology, 30, 436, 10.1016/0090-4295(87)90374-8

Barzel, 1977, Prostatic adenocarcinoma: Relationship of grade and local extent to pattern of metastases, J Urol, 118, 278, 10.1016/S0022-5347(17)57973-2

Kramer, 1980, Experience with Gleason's histopathologic grading in prostatic cancer, J Urol, 124, 223, 10.1016/S0022-5347(17)55381-1

Paulson, 1980, Predictors of lymphatic spread in prostatic carcinoma: Uro-oncology Research Group Study, J Urol, 123, 697, 10.1016/S0022-5347(17)56095-4

Thomas, 1982, Aid to accurate clinical staging—Histopathologic grading in prostatic cancer, J Urol, 128, 726, 10.1016/S0022-5347(17)53156-0

McNeal, 1990, Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate, Cancer, 66, 1225, 10.1002/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X

McNeal, 1986, Patterns of progression in prostate cancer, Lancet, 1, 60, 10.1016/S0140-6736(86)90715-4

Oesterling, 1987, Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathologic stage in 275 patients with clinically localized adenocarcinoma of the prostate, J Urol, 138, 92, 10.1016/S0022-5347(17)43003-5

Guileyardo, 1982, Incidental prostatic carcinoma: Tumor extent versus histologic grade, Urology, 20, 40, 10.1016/0090-4295(82)90534-9

Oota, 1981, Pathomorphological studies on carcinoma of the prostate in Japan, Prostate, 1, 125, 10.1002/pros.2990020520

Murphy, 1979, A report of the workshops on the current status of histologic grading of prostate cancer, Cancer, 44, 1490, 10.1002/1097-0142(197910)44:4<1490::AID-CNCR2820440444>3.0.CO;2-0

Gardner, 1987, Diagnostic nomenclature for prostate cancer, J Urol, 138, 1436, 10.1016/S0022-5347(17)43667-6

Jewett, 1975, The present status of radical prostatectomy for stages A and B prostatic cancer, Urol Clin North Am, 2, 105, 10.1016/S0094-0143(21)01061-2

Catalona, 1982, Grading errors in prostatic needle biopsies: Relation to the accuracy of predicting pelvic lymph node metastases, J Urol, 127, 919, 10.1016/S0022-5347(17)54132-4

Lange, 1983, Understaging and undergrading of prostatic cancer: Argument for postoperative radiation as adjuvant therapy, Urology, 21, 113, 10.1016/0090-4295(83)90002-X

Olsson, 1985, Staging lymphadenectomy should be an antecedent to treatment in localized prostatic carcinoma, Urology, 25, 4

Pontes, 1985, Prognostic factors in localized prostatic carcinoma, J Urol, 134, 1137, 10.1016/S0022-5347(17)47659-2

Brawn, 1983, The dedifferentiation of prostatic carcinoma, Cancer, 52, 246, 10.1002/1097-0142(19830715)52:2<246::AID-CNCR2820520210>3.0.CO;2-Q

Pool, 1956, Conservative treatment of carcinoma of the prostate, JAMA, 160, 833, 10.1001/jama.1956.02960450015004

Whitmore, 1963, The rationale and results of ablative surgery for prostatic cancer, Cancer, 16, 1119, 10.1002/1097-0142(196309)16:9<1119::AID-CNCR2820160906>3.0.CO;2-2